214 related articles for article (PubMed ID: 32956335)
21. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
[TBL] [Abstract][Full Text] [Related]
22. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
23. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
24. Powerful inner/outer controlled multi-target magnetic nanoparticle drug carrier prepared by liquid photo-immobilization.
Guan YQ; Zheng Z; Huang Z; Li Z; Niu S; Liu JM
Sci Rep; 2014 May; 4():4990. PubMed ID: 24845203
[TBL] [Abstract][Full Text] [Related]
25. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
26. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
[TBL] [Abstract][Full Text] [Related]
27. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
Zhang G; Liu F; Jia E; Jia L; Zhang Y
Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
[TBL] [Abstract][Full Text] [Related]
28. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
29. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
30. pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity.
Di Y; Li T; Zhu Z; Chen F; Jia L; Liu W; Gai X; Wang Y; Pan W; Yang X
Int J Nanomedicine; 2017; 12():5863-5877. PubMed ID: 28860753
[TBL] [Abstract][Full Text] [Related]
31. Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice.
Pan Q; Sun Y; Jin Q; Li Q; Wang Q; Liu H; Zhao S
Acta Cir Bras; 2016 Nov; 31(11):724-729. PubMed ID: 27982259
[TBL] [Abstract][Full Text] [Related]
32. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Hijaz M; Das S; Mert I; Gupta A; Al-Wahab Z; Tebbe C; Dar S; Chhina J; Giri S; Munkarah A; Seal S; Rattan R
BMC Cancer; 2016 Mar; 16():220. PubMed ID: 26979107
[TBL] [Abstract][Full Text] [Related]
33. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724
[TBL] [Abstract][Full Text] [Related]
34. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
[TBL] [Abstract][Full Text] [Related]
35. Effect of the Folate Ligand Density on the Targeting Property of Folated-Conjugated Polymeric Nanoparticles.
Gong YC; Xiong XY; Ge XJ; Li ZL; Li YP
Macromol Biosci; 2019 Feb; 19(2):e1800348. PubMed ID: 30444303
[TBL] [Abstract][Full Text] [Related]
36. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.
Slastnikova TA; Rosenkranz AA; Khramtsov YV; Karyagina TS; Ovechko SA; Sobolev AS
Drug Des Devel Ther; 2017; 11():1315-1334. PubMed ID: 28490863
[TBL] [Abstract][Full Text] [Related]
38. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
39. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
[TBL] [Abstract][Full Text] [Related]
40. Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo.
Li J; Yao S; Wang K; Lu Z; Su X; Li L; Yuan C; Feng J; Yan S; Kong B; Song K
Cancer Sci; 2018 Jun; 109(6):1958-1969. PubMed ID: 29617063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
